Lupin reports 25% fall in pre-tax profit at Rs 412 cr in Q4 on low sales

Mumbai-based drug major Lupin on Friday reported a 25 per cent dip in profit before tax (before exceptional items) in the fourth quarter of 2019-20 financial year at Rs 412 crore, as its sales declined marginally year on year (YoY) to Rs 3,791 crore.
 
On a sequential basis, however, the company fared better, both in terms of sales and profits.  The stock ended day’s trade at Rs 869.8, down 1.3 per cent.
 
Analysts said this was an operationally weak quarter led by other income and exceptional gains from the sale of the Kyowa business in Japan. Lupin had